Great interview, thanks Bpharma. After all this time with all the associated hiccups and hold ups I must admit I am still holding on and still believe this company has a massive future.Hoping for the day when they can actually sell a therapy commercially but more significantly sell a therapy that answers a huge unmet need.Just the simple idea that an infection caused by many possible different bacteria might be treated with this single compound rather than having to cross match for a specific anti biotic seems life saving.
Good luck to all holders, hopefully current deals can get this over the line.
[INTERVIEW] Recce gearing up for Indonesian trials, page-15
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
-0.005(0.88%) |
Mkt cap ! $115.2M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 57.0¢ | 56.0¢ | $24.17K | 42.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5551 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 47240 | 1 |
View Market Depth
| Last trade - 15.40pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
56.5¢ |
Change
-0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 56.5¢ | 56.5¢ | 56.5¢ | 1 | ||
| Last updated 15.43pm 07/06/2024 ? | |||||
| RCE (ASX) Chart |